SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Slides:

Advertisements

Similar presentations

Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?

Advertisements

Martin Arnold Director - Research Analyst ETF Securities.

STRICTLY CONFIDENTIAL Positioning for Growth Tasmanian Strata Industry Tim MacKenzie Associate Director Friday 9 th August.

Anticipated 2008 Generic Launches JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM © THOMSON REUTERS.

© Copyright Showeet.com I NSERT YOUR TITLE HERE. © Copyright Showeet.com Insert Your Title Here 2 Master text styles –Second level Third level –Fourth.

MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.

Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©

Paragraph IV Patent Challenges – As of July 1, 2008 JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM.

World Health Proposal. Activity 18: World Health Proposal LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.

Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.

DNA Replication. Activity 12: DNA Replication LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently teaching.

Your logo here Click to edit Master title style. Insert your slogan here 2 Master text styles –Second level Third level –Fourth level »Fifth level Customize.

Title Goes Here; 2 Lines Maximum; Choose from 1 of the 3 Title Slides Author(s): Firstname, Last name, Degree(s) Academic Affiliation : Institution, Title.

Place Client Logo Here Oil Market Outlook Paul Horsnell Head of Commodities Research, Barclays Capital Intertanko Singapore Tanker Event 30 March 2006.

Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.

Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.

2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.

Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.

Sustainability Case Studies. Activity 3: Sustainability Case Studies LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers.

Presentation Title Presentation Subtitle Presenter Name Presenter Title Presenter Company presenter presenter website These slides released under.

Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.

Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.

Your logo Click to add title Template for Microsoft PowerPoint.

Insert the title of your presentation here Insert the subtitle of your presentation here.

Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.

Ideas about Evolution. Activity 14: Ideas about Evolution LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.

The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.

Genes and Traits. Activity 5: Genes and Traits LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently teaching.

BIOLOGY / CHEMISTRY CITATIONS GROWTH

Insert Presentation Title Here Insert Presentation Summary Here

Name of Speaker, Title and Organization

Enter Presentation Title

the first card insert text here.

Protect your Business April 2018

Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA

Agenda item number 1 Agenda item number 2 Agenda item number 3 Agenda item number 4 Agenda item number 5.

Insert Presentation Title Here Insert Presentation Summary Here

, R&D expenditure showed 6% growth annually

Analysis and Discussion Summary and Conclusions

Proportion of total R&D expenditure on alliances or joint ventures by stage of R&D in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.

Market linked debentures

Subhead text can go here

Enter Presentation Title

Development time for new molecular entities first launched onto the world market between MARCH 2008 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS.

Cycle times decreased in larger but not smaller, companies

INSERT YOUR HEADLINE HERE

Insert Presentation Title Here Insert Presentation Summary Here

Type your presentation title here

Please insert Title Please insert sub-title 1

Put the title here Here is the sub-title.

Put the title here Here is the sub-title.

Summarizing Use the following slides in order to organize your understanding of the article. After filling in the graphic organizer, then write your summary.

Insert Presentation Title Here Insert Presentation Summary Here

Heading. Heading GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation.

AGENDA – Date Heading.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Insert Presentation Title Here Insert Presentation Summary Here

Heading Presented by. heading Presented by AGENDA.

GLACIER FINANCIAL SOLUTIONS (PTY) LTD IS A LICENSED FINANCIAL SERVICES PROVIDER. Any information contained in this presentation as well as.

AGENDA – Date. AGENDA – Date Heading.

Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.

Heading. Heading AGENDA – Date.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

SLIDE TITLE Presented by. SLIDE TITLE Presented by.

Nimbus fixed option by Presented by. Nimbus fixed option by Presented by.

Oxford Village Tenancy Plan Paul Trachtenberg

AGENDA. AGENDA SLIDE TITLE Presented by.

Presentation transcript:

SLIDE TITLE Presented by

AGENDA

1 2 3 Insert copy here Insert copy here Insert copy here

TEXT TEXT TEXT TEXT

HEADING Text Text Text Text

SUMMARY Glacier Financial Solutions (Pty) Ltd is a Licensed Financial Services Provider.

HEADING SUB-HEADING

GLACIER INTERNATIONAL IS A DIVISION OF SANLAM LIFE INSURANCE LIMITED LTD. The information in this presentation is provided for information purposes only and should not be construed as the rendering of advice to clients. Although we have taken reasonable steps to ensure the accuracy of the information, neither Sanlam nor any of its subsidiaries accept any liability whatsoever for any direct, indirect or consequential loss arising from the use of, or reliance in any manner on the information provided in this document. A member of the Sanlam Group Private Bag X5, Tyger Valley 7536 Email: clientservices@glacierinternational.co.za Tel +27 (0)21 917 9333 www.glacierinternational.com Reg No 1998/021121/06 Licensed Financial Services Provider